值得買(300785.SZ):實控人隋國棟已合計減持159.87萬股
格隆匯5月7日丨值得買(300785.SZ)公佈,近日,公司收到控股股東、實際控制人隋國棟函吿,截至2023年5月5日,隋國棟通過集中競價交易累計減持公司股份129.87萬股,佔公司總股本比例0.98%;通過大宗交易減持30萬股,佔公司總股本比例0.23%。同時受公司2020年限制性股票激勵計劃回購註銷限制性股票等影響,隋國棟的持股比例被動增加0.01%。因此受上述事項影響,導致隋國棟合計持有的公司股份比例變動超過1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.